ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 171 filers reported holding ASCENDIS PHARMA A/S in Q4 2021. The put-call ratio across all filers is 1.59 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,292,512 | +12.4% | 13,803 | +7.1% | 0.00% | +50.0% |
| Q2 2023 | $1,149,719 | -36.5% | 12,882 | -23.7% | 0.00% | -50.0% |
| Q1 2023 | $1,810,624 | -24.9% | 16,887 | -14.4% | 0.00% | -33.3% |
| Q4 2022 | $2,410,113 | -0.6% | 19,734 | -16.0% | 0.01% | -14.3% |
| Q3 2022 | $2,425,000 | -11.5% | 23,489 | -20.3% | 0.01% | 0.0% |
| Q2 2022 | $2,740,000 | -58.7% | 29,484 | -47.8% | 0.01% | 0.0% |
| Q1 2022 | $6,630,000 | +68.2% | 56,494 | +92.9% | 0.01% | -12.5% |
| Q4 2021 | $3,941,000 | -16.6% | 29,288 | -1.2% | 0.01% | -33.3% |
| Q3 2021 | $4,727,000 | +22.9% | 29,656 | +1.4% | 0.01% | +9.1% |
| Q2 2021 | $3,847,000 | -6.1% | 29,238 | -8.0% | 0.01% | -21.4% |
| Q1 2021 | $4,096,000 | -3.0% | 31,786 | +25.5% | 0.01% | -12.5% |
| Q4 2020 | $4,223,000 | +8.9% | 25,318 | +0.7% | 0.02% | -15.8% |
| Q3 2020 | $3,879,000 | +30.1% | 25,135 | +24.7% | 0.02% | +5.6% |
| Q2 2020 | $2,982,000 | +23.7% | 20,162 | -5.8% | 0.02% | -5.3% |
| Q1 2020 | $2,410,000 | -1.5% | 21,398 | +21.7% | 0.02% | +26.7% |
| Q4 2019 | $2,446,000 | +120.6% | 17,585 | +52.7% | 0.02% | +87.5% |
| Q3 2019 | $1,109,000 | -17.1% | 11,513 | -0.9% | 0.01% | -11.1% |
| Q2 2019 | $1,338,000 | -16.1% | 11,616 | -14.3% | 0.01% | -25.0% |
| Q1 2019 | $1,595,000 | +125.3% | 13,551 | +20.0% | 0.01% | +100.0% |
| Q4 2018 | $708,000 | +18.4% | 11,294 | +33.8% | 0.01% | +50.0% |
| Q3 2018 | $598,000 | +169.4% | 8,444 | +153.0% | 0.00% | +33.3% |
| Q2 2018 | $222,000 | +2.8% | 3,337 | +0.9% | 0.00% | 0.0% |
| Q1 2018 | $216,000 | – | 3,306 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,225,357 | $1,001,863,112 | 18.92% |
| Q Global Advisors, LLC | 195,000 | $17,404 | 12.55% |
| Sofinnova Investments, Inc. | 754,032 | $67,297,356 | 4.41% |
| Avoro Capital Advisors LLC | 3,580,555 | $319,564,534 | 4.34% |
| Finepoint Capital LP | 139,772 | $12,474,651 | 4.32% |
| Spyglass Capital Management LLC | 657,853 | $58,713,380 | 4.24% |
| Saturn V Capital Management LP | 78,442 | $7,000,948 | 3.88% |
| DAFNA Capital Management LLC | 135,212 | $12,067,671 | 3.30% |
| ARS Investment Partners, LLC | 289,860 | $25,870,005 | 3.02% |
| Ghost Tree Capital, LLC | 100,000 | $8,925,000 | 2.95% |